| Incyte Corporation | 30.8M | US$3.73B | 17.7% |
| BeOne Medicines Ltd. Class A | 8.83M | US$3.23B | 15.4% |
| Revolution Medicines, Inc. | 10.6M | US$2.18B | 10.4% |
| Kodiak Sciences Inc | 21.9M | US$2.07B | 9.8% |
| Madrigal Pharmaceuticals, Inc. | 2.14M | US$1.08B | 5.1% |
| Insmed Incorporated | 8.8M | US$1B | 4.8% |
| Kymera Therapeutics, Inc. | 8.66M | US$968M | 4.6% |
| ACADIA Pharmaceuticals Inc. | 42.9M | US$865M | 4.1% |
| GRAIL, Inc. | 4.03M | US$564M | 2.7% |
| Summit Therapeutics Inc. | 32.8M | US$554M | 2.6% |
| Rhythm Pharmaceuticals, Inc. | 5.6M | US$534M | 2.5% |
| Praxis Precision Medicines, Inc. | 1.75M | US$511M | 2.4% |
| AbCellera Biologics Inc. | 33M | US$482M | 2.3% |
| Celcuity Inc. | 4.82M | US$383M | 1.8% |
| IDEAYA Biosciences, Inc. | 5.01M | US$192M | 0.91% |
| Edgewise Therapeutics, Inc. | 3.7M | US$150M | 0.71% |
| Replimune Group, Inc. | 11M | US$146M | 0.69% |
| Roivant Sciences Ltd. | 3.66M | US$134M | 0.64% |
| Arrowhead Pharmaceuticals, Inc. | 1.71M | US$112M | 0.53% |
| Nurix Therapeutics, Inc. | 4.66M | US$110M | 0.52% |
| Immunovant, Inc. | 2.77M | US$93.6M | 0.44% |
| Celldex Therapeutics, Inc. | 2.56M | US$83.1M | 0.40% |
| Denali Therapeutics Inc. | 3.73M | US$77.2M | 0.37% |
| Dianthus Therapeutics, Inc. | 852K | US$75M | 0.36% |
| Rapport Therapeutics, Inc. | 1.55M | US$52M | 0.25% |
| Monte Rosa Therapeutics, Inc. | 4.35M | US$51.8M | 0.25% |
| Relay Therapeutics, Inc. | 2.83M | US$51M | 0.24% |
| Ionis Pharmaceuticals, Inc. | 1.02M | US$45.7M | 0.22% |
| Structure Therapeutics, Inc. | 1.43M | US$44.8M | 0.21% |
| Enliven Therapeutics, Inc. | 905K | US$41.5M | 0.20% |
| Bicycle Therapeutics PLC | 10.9M | US$40.1M | 0.19% |
| Prelude Therapeutics Incorporated | 10.1M | US$39.6M | 0.19% |
| Mirum Pharmaceuticals, Inc. | 446K | US$38.1M | 0.18% |
| Design Therapeutics, Inc. | 2.99M | US$37.6M | 0.18% |
| Stoke Therapeutics, Inc. | 1.31M | US$34.2M | 0.16% |
| Entrada Therapeutics, Inc. | 5.07M | US$32.2M | 0.15% |
| Neurogene Inc. | 992K | US$27.6M | 0.13% |
| Xencor, Inc. | 1.1M | US$27.5M | 0.13% |
| Sensei Biotherapeutics, Inc. | 803K | US$23.9M | 0.11% |
| Absci Corporation | 2.13M | US$23M | 0.11% |
| Disc Medicine, Inc. | 350K | US$22.9M | 0.11% |
| Arcus Biosciences, Inc. | 845K | US$21.8M | 0.10% |
| Generate Biomedicines, Inc. | 1.42M | US$21.4M | 0.10% |
| Taysha Gene Therapies, Inc. | 4M | US$19.5M | 0.09% |
| Aktis Oncology, Inc. | 996K | US$19.4M | 0.09% |
| Jade Biosciences, Inc. | 1.23M | US$17.3M | 0.08% |
| DBV Technologies SA | 1.46M | US$17.2M | 0.08% |
| First Tracks Biotherapeutics, Inc. | 473K | US$16.8M | 0.08% |
| Parabilis Medicines, Inc. | 500K | US$16.1M | 0.08% |
| Tectonic Therapeutic, Inc. | 608K | US$14.2M | 0.07% |
| Cytokinetics, Incorporated | 211K | US$13.9M | 0.07% |
| Xenon Pharmaceuticals Inc. | 370K | US$13.8M | 0.07% |
| CytomX Therapeutics, Inc. | 4.98M | US$13.5M | 0.06% |
| Dyne Therapeutics, Inc. | 813K | US$13.1M | 0.06% |
| Scribe Therapeutics Inc. | 689K | US$12.7M | 0.06% |
| Freenome, Inc. | 795K | US$12.5M | 0.06% |
| MapLight Therapeutics, Inc. | 1.17M | US$11.9M | 0.06% |
| BioNTech SE | 120K | US$11.8M | 0.06% |
| Sera Prognostics, Inc. | 5.5M | US$11.5M | 0.05% |
| Evommune, Inc. | 1.23M | US$10.2M | 0.05% |
| Intellia Therapeutics, Inc. | 829K | US$10M | 0.05% |
| Avalyn Pharma Inc. | 350K | US$9.97M | 0.05% |
| Avalo Therapeutics, Inc. | 550K | US$8.43M | 0.04% |
| Tango Therapeutics, Inc. | 333K | US$8.32M | 0.04% |
| LB Pharmaceuticals Inc | 200K | US$7.68M | 0.04% |
| Protara Therapeutics, Inc. | 1.84M | US$5.62M | 0.03% |
| Cerus Corporation | 2.33M | US$5.55M | 0.03% |
| vTv Therapeutics Inc. | 148K | US$4.57M | 0.02% |
| Q32 Bio Inc. | 548K | US$4.53M | 0.02% |
| Eikon Therapeutics, Inc. | 556K | US$4.47M | 0.02% |
| Immunome, Inc. | 55,306 | US$1.19M | <0.01% |
| Sana Biotechnology, Inc. | 310K | US$905K | <0.01% |
| TScan Therapeutics, Inc. | 2.78M | US$876K | <0.01% |
| Aligos Therapeutics, Inc. | 83,055 | US$468K | <0.01% |
| Tyra Biosciences, Inc. | 10,607 | US$232K | <0.01% |
| Alumis Inc. | 0 | US$0 | 0.00% |
| Crinetics Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Sagimet Biosciences Inc. - Series A | 0 | US$0 | 0.00% |
| Sionna Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Skye Bioscience, Inc. | 0 | US$0 | 0.00% |
| Verastem, Inc. | 0 | US$0 | 0.00% |
| Viridian Therapeutics, Inc. | 0 | US$0 | 0.00% |